References
- Afshari, A., & Sayyed-Alangi, S. Z. (2017). Antioxidant effect of leaf extracts from Cressa cretica against oxidation process in soybean oil. Food Science & Nutrition, 5(2), 324–333. https://doi.org/https://doi.org/10.1002/fsn3.396
- Altay, O., Mohammadi, E., Lam, S., Turkez, H., Boren, J., Nielsen, J., Uhlen, M., & Mardinoglu, A. (2020). Current status of COVID-19 therapies and drug repositioning applications. IScience, 23(7), 101303. https://doi.org/https://doi.org/10.1016/j.isci.2020.101303
- Anang, S., Kaushik, N., Hingane, S., Kumari, A., Gupta, J., Asthana, S., Shalimar, Nayak, B., Ranjith-Kumar, C. T., & Surjit, M. (2018). Potent inhibition of hepatitis E virus release by a cyclic peptide inhibitor of the interaction between viral open reading frame 3 protein and host tumor susceptibility gene 101. Journal of Virology, 92(20), e00684–18. https://doi.org/https://doi.org/10.1128/JVI.00684-18
- Astuti, I. & Ysrafil, (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes & Metabolic Syndrome, 14(4), 407–412. https://doi.org/https://doi.org/10.1016/j.dsx.2020.04.020
- Benfenati, E., Chaudhry, Q., Gini, G., & Dorne, J. L. (2019). Integrating in silico models and read-across methods for predicting toxicity of chemicals: A step-wise strategy. Environment International, 131, 105060. https://doi.org/https://doi.org/10.1016/j.envint.2019.105060
- Bhardwaj, V. K., Singh, R., Sharma, J., Rajendran, V., Purohit, R., & Kumar, S. (2020). Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1766572
- Cai, Q., Yang, M., Liu, D., Chen, J., Shu, D., Xia, J., Liao, X., Gu, Y., Cai, Q., Yang, Y., Shen, C., Li, X., Peng, L., Huang, D., Zhang, J., Zhang, S., Wang, F., Liu, J., Chen, L., … Liu, L. (2020). Experimental treatment with favipiravir for COVID-19. Engineering, 6(10), 1192–1198. https://doi.org/https://doi.org/10.1016/j.eng.2020.03.007
- Chaudhry, Q., Piclin, N., Cotterill, J., Pintore, M., Price, N. R., Chrétien, J. R., & Roncaglioni, A. (2010). Global QSAR models of skin sensitisers for regulatory purposes. Chemistry Central Journal, 4 (Suppl 1), S5–S5. https://doi.org/https://doi.org/10.1186/1752-153X-4-S1-S5
- Costanzo, M., De Giglio, M. A. R., & Roviello, G. N. (2020). SARS-CoV-2: Recent reports on antiviral therapies based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other drugs for the treatment of the new coronavirus. Current Medicinal Chemistry, 27(27), 4536–4541. https://doi.org/https://doi.org/10.2174/0929867327666200416131117
- Cotterill, J. V., Palazzolo, L., Ridgway, C., Price, N., Rorije, E., Moretto, A., Peijnenburg, A., & Eberini, I. (2019). Predicting estrogen receptor binding of chemicals using a suite of in silico methods - Complementary approaches of (Q)SAR, molecular docking and molecular dynamics. Toxicology and Applied Pharmacology, 378, 114630. https://doi.org/https://doi.org/10.1016/j.taap.2019.114630
- Devrnja, N., Anđelković, B., Aranđelović, S., Radulović, S., Soković, M., Krstić-Milošević, D., Ristić, M., & Ćalić, D. (2017). Comparative studies on the antimicrobial and cytotoxic activities of Tanacetum vulgare L. essential oil and methanol extracts. South African Journal of Botany, 111, 212–221. https://doi.org/https://doi.org/10.1016/j.sajb.2017.03.028
- Elfiky, A. A. (2020a). Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sciences, 253(February), 117592. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117592
- Elfiky, A. A. (2020b). SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: An in silico perspective. Journal of Biomolecular Structure & Dynamics, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1761882
- Fjodorova, N., Vracko, M., Novic, M., Roncaglioni, A., & Benfenati, E. (2010). New public QSAR model for carcinogenicity. Chemistry Central Journal, 4 (Suppl 1), S3–S3. https://doi.org/https://doi.org/10.1186/1752-153X-4-S1-S3
- Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/https://doi.org/10.1021/jm0306430
- Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/https://doi.org/10.1021/jm051256o
- Genheden, S., & Ryde, U. (2015). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/https://doi.org/10.1517/17460441.2015.1032936
- Gordon, C., Tchesnokov, E., Feng, J., Porter, D., & Gotte, M. (2020). The antiviral compound Remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. Journal of Biological Chemistry, 295(15), 4773–4779. https://doi.org/https://doi.org/10.1074/jbc.AC120.013056
- Gordon, C. J., Tchesnokov, E. P., Woolner, E., Perry, J. K., Feng, J. Y., Porter, D. P., & Götte, M. (2020). Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. The Journal of Biological Chemistry, 295(20), 6785–6797. https://doi.org/https://doi.org/10.1074/jbc.RA120.013679
- Hall, D. C., & Ji, H.-F. (2020). A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease. Travel Medicine and Infectious Disease, 35, 101646. https://doi.org/https://doi.org/10.1016/j.tmaid.2020.101646
- Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00864
- Jean, S.-S., & Hsueh, P.-R. (2020). Old and re-purposed drugs for the treatment of COVID-19. Expert Review of anti-Infective Therapy, 18(9), 843–845. https://doi.org/https://doi.org/10.1080/14787210.2020.1771181
- Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society, 118(45), 11225–11236. https://doi.org/https://doi.org/10.1021/ja9621760
- Kandeel, M., & Al-Nazawi, M. (2020). Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sciences, 251, 117627. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117627
- Kotha, S., B, S., Kulkarni, V. M., S, R. S., B, H. K., & R, H. (2020). An in-silico approach: Identification of PPAR-γ agonists from seaweeds for the management of Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics, 1–20. https://doi.org/https://doi.org/10.1080/07391102.2020.1747543
- Li, J., Abel, R., Zhu, K., Cao, Y., Zhao, S., & Friesner, R. A. (2011). The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins, 79(10), 2794–2812. https://doi.org/https://doi.org/10.1002/prot.23106
- Li, Y., But, P. P. H., & Ooi, V. E. C. (2005). Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin. Antiviral Research, 68(1), 1–9. https://doi.org/https://doi.org/10.1016/j.antiviral.2005.06.004
- Mansouri, K., Kleinstreuer, N., Abdelaziz, A. M., Alberga, D., Alves, V. M., Andersson, P. L., Andrade, C. H., Bai, F., Balabin, I., Ballabio, D., Benfenati, E., Bhhatarai, B., Boyer, S., Chen, J., Consonni, V., Farag, S., Fourches, D., García-Sosa, A. T., Gramatica, P., … Judson, R. S. (2020). CoMPARA: Collaborative modeling project for androgen receptor activity. Environmental Health Perspectives, 128(2), 27002 https://doi.org/https://doi.org/10.1289/EHP5580
- Masters, P. S. (2006). The molecular biology of coronaviruses. Advances in Virus Research. https://doi.org/https://doi.org/10.1016/S0065-3527(06)66005-3
- Meyer-Almes, F.-J. (2020). Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design. Computational Biology and Chemistry, 88, 107351. https://doi.org/https://doi.org/10.1016/j.compbiolchem.2020.107351
- Mukhtar, M., Arshad, M., Ahmad, M., Pomerantz, R. J., Wigdahl, B., & Parveen, Z. (2008). Antiviral potentials of medicinal plants. Virus Research, 131(2), 111–120. https://doi.org/https://doi.org/10.1016/j.virusres.2007.09.008
- National Institutes of Health. (n.d). COVID-19 treatment guidelines panel. Coronavirus disease 2019 (COVID-19) treatment guidelines. https://www.covid19treatmentguidelines.nih.gov/therapeutic-management
- Ooi, L. S. M., Wang, H., He, Z., & Ooi, V. E. C. (2006). Antiviral activities of purified compounds from Youngia japonica (L.) DC (Asteraceae, Compositae). Journal of Ethnopharmacology, 106(2), 187–191. https://doi.org/https://doi.org/10.1016/j.jep.2005.12.028
- Priyashree, S., Jha, S., & Pattanayak, S. (2010). A review on Cressa cretica Linn.: A halophytic plant. In Pharmacognosy Reviews. https://doi.org/https://doi.org/10.4103/0973-7847.70910
- Rani, S., Singh, P., Mishra, G., Jha, K. K., & Khosa, R. L. (2011). Cressa cretica Linn. - An important medicinal plant: A review on its traditional uses, phytochemistry and pharmacological properties. Journal of Natural Product & Plant Resources, 1, 91–100.
- Release, S. (2017). 1: Maestro. Schrödinger, LLC.
- Rogiers, V., Benfenati, E., Bernauer, U., Bodin, L., Carmichael, P., Chaudhry, Q., Coenraads, P. J., Cronin, M. T. D., Dent, M., Dusinska, M., Ellison, C., Ezendam, J., Gaffet, E., Galli, C. L., Goebel, C., Granum, B., Hollnagel, H. M., Kern, P. S., Kosemund-Meynen, K., … Worth, A. (2020). The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings. Toxicology, 436, 152421 https://doi.org/https://doi.org/10.1016/j.tox.2020.152421
- Russo, M., Moccia, S., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2020). Roles of flavonoids against coronavirus infection. Chemico-biological Interactions, 328, 109211. https://doi.org/https://doi.org/10.1016/j.cbi.2020.109211
- Sen, D. (2009). Cressa cretica Linn. - In search of Sanjeevani. Current Science, 97(11), 1523-1523. http://www.jstor.org/stable/24107281
- Shah, B., Modi, P., & Sagar, S. R. (2020). In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sciences, 252, 117652. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117652
- Shahat, A. A., Abdel-Azim, N. S., Pieters, L., & Vlietinck, A. J. (2004). Flavonoids from Cressa cretica. Pharmaceutical Biology, 42(4-5), 349–352. https://doi.org/https://doi.org/10.1080/13880200490519622
- Shannon, A., Le, N. T.-T., Selisko, B., Eydoux, C., Alvarez, K., Guillemot, J.-C., Decroly, E., Peersen, O., Ferron, F., & Canard, B. (2020). Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. Antiviral Research, 178, 104793. https://doi.org/https://doi.org/10.1016/j.antiviral.2020.104793
- Siemieniuk, R. A. C., Bartoszko, J. J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Rochwerg, B., Lamontagne, F., Han, M. A., Liu, Q., Agarwal, A., Agoritsas, T., Chu, D. K., Couban, R., Darzi, A., Devji, T., Fang, B., Fang, C., … Brignardello-Petersen, R. (2020). Drug treatments for covid-19: Living systematic review and network meta-analysis. BMJ, 370, m2980. https://doi.org/https://doi.org/10.1136/bmj.m2980
- Simms, L., Rudd, K., Palmer, J., Czekala, L., Yu, F., Chapman, F., Trelles Sticken, E., Wieczorek, R., Bode, L. M., Stevenson, M., & Walele, T. (2020). The use of human induced pluripotent stem cells to screen for developmental toxicity potential indicates reduced potential for non-combusted products, when compared to cigarettes. Current Research in Toxicology, 1, 161–173. https://doi.org/https://doi.org/10.1016/j.crtox.2020.11.001
- Suganthi, G., Sripathy, S. K., & Manian, K. (2008). HPTLC and antibacterial analysis of extracts of Cressa cretica Linn. Ancient Science of Life, 27(3), 1–14. https://pubmed.ncbi.nlm.nih.gov/22557271
- Sunita, P., Jha, S., & Pattanayak, S. P. (2011). Anti-inflammatory and in-vivo antioxidant activities of Cressa cretica Linn., a halophytic plant. Middle-East Journal of Scientific Research, 8(1), 129–140.
- Viveiros Rosa, S. G., & Santos, W. C. (2020). Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana de Salud Pública, 44, 1. https://doi.org/https://doi.org/10.26633/RPSP.2020.40
- Vlachakis, D., Papakonstantinou, E., Mitsis, T., Pierouli, K., Diakou, I., Chrousos, G., & Bacopoulou, F. (2020). Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association, 146, 111805. https://doi.org/https://doi.org/10.1016/j.fct.2020.111805
- Votano, J. R., Parham, M., Hall, L. H., Kier, L. B., Oloff, S., Tropsha, A., Xie, Q., & Tong, W. (2004). Three new consensus QSAR models for the prediction of Ames genotoxicity. Mutagenesis, 19(5), 365–377. https://doi.org/https://doi.org/10.1093/mutage/geh043
- World Health Organization (WHO). (2020). Novel Coronavirus (2019-nCoV) Situation Report - 71. 31 March 2020. In World Health Organization. https://doi.org/https://doi.org/10.1001/jama.2020.2633
- Wu, R., Wang, L., Kuo, H.-C D., Shannar, A., Peter, R., Chou, P. J., Li, S., Hudlikar, R., Liu, X., Liu, Z., Poiani, G. J., Amorosa, L., Brunetti, L., & Kong, A.-N. (2020). An update on current therapeutic drugs treating COVID-19. Current Pharmacology Reports, 6(3), 56–15. https://doi.org/https://doi.org/10.1007/s40495-020-00216-7
- Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020). Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective. International Journal of Biological Sciences, 16(10), 1708–1717. https://doi.org/https://doi.org/10.7150/ijbs.45538
- Yunta, M. (2017). It is important to compute intramolecular hydrogen bonding in drug design? American Journal of Modelling and Optimization, 5, 24–57. https://doi.org/https://doi.org/10.12691/ajmo-5-1-3